Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
SCHAUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched amiodarone HCl injection, USP, a class III antiarrhythmic indicated for the treatment and prophylaxis of frequently recurring ventricu...New Drug Shows Promise Against Heartbeat Abnormality
...el blockers. Dronedarone is a chemical relative of amiodarone, a drug that has severe side effects but still is widely used in atrial fibrillation. amiodarone includes iodine, which can cause thyroid problems, and "it takes a while to have an effect," Page said. "You must give relatively high doses early to ...Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare
...l, patent-protected, cosolvent free formulation of the antiarrhythmic agent amiodarone IV. The long range financing agreement with Paul Capital Healthcare, estab... great potential of the company's approach to an alternative formulation of amiodarone and other drugs, and our belief in management's ability to bring new produc...Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
... drug application (NDA) for NEXTERONE(R) (amiodarone HCl) Injection, a novel, patent-protected, cosolvent free formulation of the antiarrhythmic agent amiodarone IV. The presentation will be webcast live by visiting the Company's website at http://www.prismpharma.com . An archive of the presentation al...Drug, Pacemaker Fight Irregular Heartbeat
...incidence of dangerous side effects -- such as occur with an approved drug, amiodarone -- was low in the dronedarone trial, said lead researcher Dr. Bramah N. Sin...gh, a professor of medicine at the University of California at Los Angeles. amiodarone can affect the thyroid, liver and lungs. "Up to this time, there have be...Clamor for Catheter-based Ablation Increasing Among Heart Patients in US
...ate clinical tests, they have not gained approval for atrial fibrillation. Developed for other heart problems, they include anti-arrythmia agents like amiodarone and generic sotalol, along with anti-clotting drugs, like warfarin. But doctors and patients alike have been dismayed by the side effects of the drugs...Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
...iotic. Sagent will offer ceftazidime in 1 and 2g single dose vials and 6g pharmacy bulk package vials. According to IMS data, 2007 sales of injectable amiodarone in the United States were approximately $45.7 million. "Sagent is proud to be providing tools to the healthcare community that have the potential to...